NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrogen Peroxide | HYDROGEN PEROXIDE | Retail Business Services, LLC | 2cc09239-a1d4-4276-adc4-82fdc396e23a | 2026-04-29 | Warnings, Adverse reactions | M003 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Perrigo Direct, Inc | 11d89d11-103e-4ef6-a996-65cff67f9b32 | 2026-04-29 | Warnings, Adverse reactions | M003 ND2M416302 |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 509cad98-0321-2a0a-e063-6294a90a6ea9 | 2026-04-29 | Warnings | 15FIX9V2JP |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Walmart Inc. | 1fd3d29f-7da0-c5ba-e063-6294a90add16 | 2026-04-29 | Warnings, Adverse reactions | M003 ND2M416302 |
| Summit 375 Gel Alcohol Hand Sanitizer | ALCOHOL | R.L. Williams Company | 509cc442-09f8-d17f-e063-6394a90a77ea | 2026-04-29 | Warnings | 3K9958V90M |
| Ethyl Alcohol | ETHYL ALCOHOL | Walmart Inc. | 1fd3bed0-8fcc-2cee-e063-6294a90a34fb | 2026-04-29 | Warnings, Adverse reactions | M003 3K9958V90M |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 509d7206-0cc1-c997-e063-6294a90a89e0 | 2026-04-29 | Warnings | 15FIX9V2JP |
| Panadol Cold and Flu Day | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Haleon US Holdings LLC | 341761b9-f0be-f816-e063-6394a90a5e63 | 2026-04-29 | Warnings | 362O9ITL9D |
| 1438 DynaSoap | ANTIBACTERIAL HAND SOAP | Dynarex Corporation | ab0d5f64-9168-2ea3-e053-2a95a90a321e | 2026-04-29 | Warnings | M003 F5UM2KM3W7 |
| Panadol Cold and Flu Night | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | Haleon US Holdings LLC | 3417993d-8e3c-23d6-e063-6394a90a7d50 | 2026-04-29 | Warnings | 362O9ITL9D |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| Summit 367 Antibacterial Foam | BENZALKONIUM CHLORIDE | R.L. Williams Company | 509f2491-ea17-86ee-e063-6394a90a5940 | 2026-04-29 | Warnings | F5UM2KM3W7 |
| E2 Antibacterial Foaming Skin Cleanser | BENZALKONIUM CHLORIDE | Betco Corporation, Ltd. | aa7c24bb-cc66-3081-e053-2a95a90ada03 | 2026-04-29 | Warnings | F5UM2KM3W7 |
| MHB SKIN HYDRATING HAND SANITIZER, LILY MIST | ALCOHOL HAND SANITIZER | CROWN (YANGZHOU) HEALTH & BEAUTY CO., LTD. | 50949ae2-3ebe-08d2-e063-6394a90a2046 | 2026-04-29 | Warnings | 3K9958V90M |
| MHB SKIN HYDRATING HAND SANITIZER SANTAL WAVE 35ml | ALCOHOL HAND SANITIZER | CROWN (YANGZHOU) HEALTH & BEAUTY CO., LTD. | 493120ee-0c5c-b704-e063-6394a90a8c19 | 2026-04-29 | Warnings | 3K9958V90M |
| JMSOLUTION SKIN BOOST NIACINAMIDE SUNSCREEN | HOMOSALATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE | GPNY CORP | 211dea04-faad-8ffc-e063-6294a90a8d68 | 2026-04-29 | Warnings | 15FIX9V2JP |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | B697894SGQ FZ989GH94E |
| Up and Up Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Target Corporation | acaffae6-2964-4529-b61a-19ddfc5fd669 | 2026-04-29 | Warnings | R16CO5Y76E 362O9ITL9D |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals, Inc. | a23fc1e0-2d16-43a8-a34e-f6505dcd6316 | 2026-04-29 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| EQUATE MENSTRUAL PAIN RELIEF | ACETAMINOPHEN | WALMART INC. | e387ae77-27e9-455a-b708-43288411b2c1 | 2026-04-29 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.